Your browser doesn't support javascript.
loading
Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutations.
Li, Ning; Yao, Qiu-Mei; Gale, Robert Peter; Li, Jin-Lan; Li, Ling-Di; Zhao, Xiao-Su; Jiang, Hao; Jiang, Qian; Jiang, Bin; Shi, Hong-Xia; Chen, Shan-Shan; Liu, Kai-Yan; Huang, Xiao-Jun; Ruan, Guo-Rui.
Afiliação
  • Li N; Peking University People's Hospital and Institute of Hematology, 11 Xi-Zhi-Men South Street, Beijing 100044, China.
  • Yao QM; Peking University People's Hospital and Institute of Hematology, 11 Xi-Zhi-Men South Street, Beijing 100044, China.
  • Gale RP; Haematology Research Center, Division of Experimental Medicine, Department of Medicine, Imperial College London, W12 OHS London, United Kingdom.
  • Li JL; Peking University People's Hospital and Institute of Hematology, 11 Xi-Zhi-Men South Street, Beijing 100044, China.
  • Li LD; Peking University People's Hospital and Institute of Hematology, 11 Xi-Zhi-Men South Street, Beijing 100044, China.
  • Zhao XS; Peking University People's Hospital and Institute of Hematology, 11 Xi-Zhi-Men South Street, Beijing 100044, China.
  • Jiang H; Peking University People's Hospital and Institute of Hematology, 11 Xi-Zhi-Men South Street, Beijing 100044, China.
  • Jiang Q; Peking University People's Hospital and Institute of Hematology, 11 Xi-Zhi-Men South Street, Beijing 100044, China.
  • Jiang B; Peking University People's Hospital and Institute of Hematology, 11 Xi-Zhi-Men South Street, Beijing 100044, China.
  • Shi HX; Peking University People's Hospital and Institute of Hematology, 11 Xi-Zhi-Men South Street, Beijing 100044, China.
  • Chen SS; Peking University People's Hospital and Institute of Hematology, 11 Xi-Zhi-Men South Street, Beijing 100044, China.
  • Liu KY; Peking University People's Hospital and Institute of Hematology, 11 Xi-Zhi-Men South Street, Beijing 100044, China.
  • Huang XJ; Peking University People's Hospital and Institute of Hematology, 11 Xi-Zhi-Men South Street, Beijing 100044, China.
  • Ruan GR; Peking University People's Hospital and Institute of Hematology, 11 Xi-Zhi-Men South Street, Beijing 100044, China. Electronic address: ruanguorui@pkuph.edu.cn.
Leuk Res ; 39(5): 510-4, 2015 May.
Article em En | MEDLINE | ID: mdl-25746303
ABSTRACT
CALR mutations are detected in about 50% of persons of predominately European descent with essential thrombocythemia (ET) or primary myelofibrosis (PMF) with wild-type alleles of JAK2 and MPL. We studied 1088 Chinese with diverse myeloproliferative neoplasms including ET (N=234) and PMF (N=50) without JAK2(V617F) or MPL exon 10 mutations. CALR mutation was detected in 53% (95% CI, 46-60%) of subjects with ET and 56% (95% CI, 41-70%) of subjects with PMF. 152 CALR mutations were identified clustering into 15 types including deletions (N=8), insertions (N=3) and complex indels (N=4). We also identified 9 new mutations. Mean (±SD) mutant allele burden was 31±12% (range, 0.5-69%). Persons with PMF had higher CALR mutant allele burdens than those with ET (38±8% vs. 29±12%; P<0.001). Amongst persons with CALR mutations, those with PMF had different clinical features from those with ET. These data may be useful for diagnosing ET and PMF in Chinese who are about 40% of all persons with ET and PMF and for monitoring therapy-response. They also highlight similarities and differences in CALR mutations between Chinese and persons of predominately European descent with these diseases.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Calreticulina / Mielofibrose Primária / Trombocitemia Essencial / Mutação Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Calreticulina / Mielofibrose Primária / Trombocitemia Essencial / Mutação Idioma: En Ano de publicação: 2015 Tipo de documento: Article